172 related articles for article (PubMed ID: 26537841)
21. The Road to Infection: Host-Microbe Interactions Defining the Pathogenicity of
Jans C; Boleij A
Front Microbiol; 2018; 9():603. PubMed ID: 29692760
[TBL] [Abstract][Full Text] [Related]
22. Streptococcus gallolyticus abrogates anti-carcinogenic properties of tannic acid on low-passage colorectal carcinomas.
Oehmcke-Hecht S; Mandl V; Naatz LT; Dühring L; Köhler J; Kreikemeyer B; Maletzki C
Sci Rep; 2020 Mar; 10(1):4714. PubMed ID: 32170212
[TBL] [Abstract][Full Text] [Related]
23. Variations among Streptococcus gallolyticus subsp. gallolyticus strains in connection with colorectal cancer.
Kumar R; Herold JL; Taylor J; Xu J; Xu Y
Sci Rep; 2018 Jan; 8(1):1514. PubMed ID: 29367658
[TBL] [Abstract][Full Text] [Related]
24. Streptococcus gallolyticus infection: A neglected marker for colorectal cancer?
Bin Ismail CMKH; Bin Mohammad Aidid E; Binti Hamzah HA; Bin Shalihin MSE; Bin Md Nor A
Arab J Gastroenterol; 2023 Aug; 24(3):163-167. PubMed ID: 37156704
[TBL] [Abstract][Full Text] [Related]
25. Detection of
Périchon B; Lichtl-Häfele J; Bergsten E; Delage V; Trieu-Cuot P; Sansonetti P; Sobhani I; Dramsi S
Front Cell Infect Microbiol; 2022; 12():794391. PubMed ID: 35360109
[TBL] [Abstract][Full Text] [Related]
26. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis.
Boleij A; van Gelder MM; Swinkels DW; Tjalsma H
Clin Infect Dis; 2011 Nov; 53(9):870-8. PubMed ID: 21960713
[TBL] [Abstract][Full Text] [Related]
27. Streptococcus gallolyticus infection in colorectal cancer and association with biological and clinical factors.
Andres-Franch M; Galiana A; Sanchez-Hellin V; Ochoa E; Hernandez-Illan E; Lopez-Garcia P; Castillejo A; Castillejo MI; Barbera VM; Garcia-Dura J; Gomez-Romero FJ; Royo G; Soto JL
PLoS One; 2017; 12(3):e0174305. PubMed ID: 28355283
[TBL] [Abstract][Full Text] [Related]
28. Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor development.
Kumar R; Herold JL; Schady D; Davis J; Kopetz S; Martinez-Moczygemba M; Murray BE; Han F; Li Y; Callaway E; Chapkin RS; Dashwood WM; Dashwood RH; Berry T; Mackenzie C; Xu Y
PLoS Pathog; 2017 Jul; 13(7):e1006440. PubMed ID: 28704539
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany.
Zhang Y; Hoffmeister M; Weck MN; Chang-Claude J; Brenner H
Am J Epidemiol; 2012 Mar; 175(5):441-50. PubMed ID: 22294430
[TBL] [Abstract][Full Text] [Related]
30. Association of Pre-diagnostic Antibody Responses to Escherichia coli and Bacteroides fragilis Toxin Proteins with Colorectal Cancer in a European Cohort.
Butt J; Jenab M; Werner J; Fedirko V; Weiderpass E; Dahm CC; Tjønneland A; Olsen A; Boutron-Ruault MC; Rothwell JA; Severi G; Kaaks R; Turzanski-Fortner R; Aleksandrova K; Schulze M; Palli D; Pala V; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Van Gils CH; Gram IT; Lukic M; Sala N; Sánchez Pérez MJ; Ardanaz E; Chirlaque MD; Palmquist R; Löwenmark T; Travis RC; Heath A; Cross AJ; Freisling H; Zouiouich S; Aglago E; Waterboer T; Hughes DJ
Gut Microbes; 2021; 13(1):1-14. PubMed ID: 33874856
[TBL] [Abstract][Full Text] [Related]
31. Streptococcus gallolyticus bacteraemia in hepatobiliary-pancreatic and colonic pathologies.
Zammit SC; Azzopardi N; Ellul P
QJM; 2014 May; 107(5):355-61. PubMed ID: 24368857
[TBL] [Abstract][Full Text] [Related]
32. Characteristics and natural history of patients with colorectal cancer complicated by infectious endocarditis. Case control study of 25 patients.
Ouaïssi M; Studer AS; Mege D; Thuny F; Boiron L; Loundou A; Pirrò N; Hamed S; Frasconi C; Habib G; Fournier PE; Collart F; Sielezneff I; Sastre B
Anticancer Res; 2014 Jan; 34(1):349-53. PubMed ID: 24403486
[TBL] [Abstract][Full Text] [Related]
33. Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer.
Boleij A; Muytjens CM; Bukhari SI; Cayet N; Glaser P; Hermans PW; Swinkels DW; Bolhuis A; Tjalsma H
J Infect Dis; 2011 Apr; 203(8):1101-9. PubMed ID: 21451000
[TBL] [Abstract][Full Text] [Related]
34. The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease.
Boleij A; Tjalsma H
Lancet Infect Dis; 2013 Aug; 13(8):719-24. PubMed ID: 23831427
[TBL] [Abstract][Full Text] [Related]
35. Immune response against Streptococcus gallolyticus in patients with adenomatous polyps in colon.
Garza-González E; Ríos M; Bosques-Padilla FJ; Francois F; Cho I; González GM; Pérez-Pérez GI
Int J Cancer; 2012 Nov; 131(10):2294-9. PubMed ID: 22377818
[TBL] [Abstract][Full Text] [Related]
36. Relationship among
Romay E; Pericàs JM; García-País MJ; Hernández-Meneses M; Ayuso B; García-González J; Garcés-Durán RV; Rabuñal R; Alonso-García P; García-Garrote F; Perissinotti A; Vidal B; Falces C; Quintana E; Moreira L; Almela M; Llach J; Moreno A; Corredoira J; Miró JM; On Behalf Of Lucus Augusti And Hospital Clinic Endocarditis Teams
J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456274
[TBL] [Abstract][Full Text] [Related]
37. Bacteraemia due to Streptococcus gallolyticus subspecies pasteurianus is associated with digestive tract malignancies and resistance to macrolides and clindamycin.
Sheng WH; Chuang YC; Teng LJ; Hsueh PR
J Infect; 2014 Aug; 69(2):145-53. PubMed ID: 24637236
[TBL] [Abstract][Full Text] [Related]
38. Association between colorectal cancer and Streptococcus gallolyticus subsp. pasteuranus (former S. bovis) endocarditis: clinical relevance and cues for microbiota science. Case report and review of the literature.
Agnes A; Biondi A; Belia F; Di Giambenedetto S; Addolorato G; Antonelli M; D'Ugo D; Persiani R
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):480-486. PubMed ID: 33506939
[TBL] [Abstract][Full Text] [Related]
39. [Diseases associated with bloodstream infections caused by the new species included in the old Streptococcus bovis group].
Gómez-Garcés JL; Gil Y; Burillo A; Wilhelmi I; Palomo M
Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):175-9. PubMed ID: 22377494
[TBL] [Abstract][Full Text] [Related]
40. Characterization of TelE, a T7SS LXG Effector Exhibiting a Conserved C-Terminal Glycine Zipper Motif Required for Toxicity.
Teh WK; Ding Y; Gubellini F; Filloux A; Poyart C; Givskov M; Dramsi S
Microbiol Spectr; 2023 Aug; 11(4):e0148123. PubMed ID: 37432124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
